SCHEMBL7224414

SCHEMBL7224414

CNC(=O)c1ccc2c(c1)C(=C(C)Nc1ccc(CN(C)C)cc1)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 6/20 0.41
AKT2 P31751 4/20 0.39
CYP3A4 P08684 2/20 0.38
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
DYRK1A Q13627 1/20 0.38
LSS P48449 1/20 0.38
PDPK1 O15530 2/20 0.37
CYP2C19 P33261 1/20 0.37
FCER2 P06734 1/20 0.37
SYK P43405 1/20 0.37
AKT1 P31749 1/20 0.37
LRRK2 Q5S007 1/20 0.36
JAK3 P52333 1/20 0.36
SLC2A1 P11166 1/20 0.36
HSP90AA1 P07900 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224411 1.00 ROCK2 (0.41) ROCK2AKT2CYP3A4PDK2PDK4
SCHEMBL7233622 0.90 ACHE (0.44)
SCHEMBL7233617 0.90 ACHE (0.44)
SCHEMBL7227045 0.89 KDM1A (0.39) ROCK2AKT2PDPK1FCER2SYK
SCHEMBL7227041 0.89 KDM1A (0.39) ROCK2AKT2PDPK1FCER2SYK
SCHEMBL7227276 0.89 JAK3 (0.42) ROCK2AKT2PDK2PDK4CLK2
SCHEMBL7227283 0.89 JAK3 (0.42) ROCK2AKT2PDK2PDK4CLK2
SCHEMBL6982529 0.88 ROCK2 (0.43) ROCK2CYP3A4CYP2C19SLC2A1
SCHEMBL6982535 0.88 ROCK2 (0.43) ROCK2CYP3A4CYP2C19SLC2A1
SCHEMBL7233897 0.88 NAMPT (0.41) ROCK2AKT2CYP3A4LSSPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed